Trading Update

Advanced Medical Solutions Grp PLC
12 December 2006


For immediate release                                          12 December 2006



                       Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')


                                 Trading Update


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
woundcare technology company, today announces an update on current trading prior
to its close period for the year to 31 December 2006. The Company's preliminary
results will be announced in March 2007.


Dr. Geoffrey Vernon, Chairman of Advanced Medical Solutions Group plc, stated:


'The expected excellent progress has been delivered during the second half of
the year and I am therefore pleased to report that the resultant cash generation
and profitability mean that the Company is trading at the top end of market
expectations.


'This is a very exciting time for AMS. Our organic business continues to perform
well across key products and geographies. We are seeing the widening acceptance
of our ActivHeal(R) woundcare range by NHS Trusts in the UK, we have broadened
our presence in the dynamic global silver alginate market, and successful
regulatory submissions to the FDA have increased our access to the lucrative US
market for our tissue adhesives and sealants technology.


'Also, the move to profitability and strong cash position is allowing management
to consider suitable bolt-on acquisitions to leverage AMS' technology and
distribution base.'


                                     -ENDS-



For further information, please contact:

Advanced Medical Solutions Group plc                Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                             Tel: [phone]
Mark Court, Mary-Jane Johnson



Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $13 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.

AMS's technology and products currently serve the majority of the key global
markets and strategic partners.


                      This information is provided by RNS
            The company news service from the London Stock Exchange